Advances in 3D Vascularized Tumor-on-a-Chip Technology

Area of Science:

• Oncology
• Biotechnology
• Biomedical Engineering

Background:

• Tumors disrupt homeostasis by proliferating rapidly, recruiting blood vessels for nutrients and oxygen.
• The immune system recruits lymphatic vessels to induce tumor cell death, highlighting the importance of tumor dynamics in cancer therapy.
• Understanding tumor microenvironments is crucial for developing effective anti-cancer treatments.

Purpose of the Study:

• To explore the capability of tumor-on-a-chip technology in mimicking organ-specific angiogenic and lymphangiogenic tumor microenvironments.
• To investigate the application of microfluidic systems in manipulating cancer development and status for therapeutic validation.
• To discuss the mechanisms of anti-cancer drugs concerning tumor growth, angiogenesis, and lymphangiogenesis.

Main Methods:

• Utilizing microfluidic systems to create tumor-on-a-chip models.
• Mimicking angiogenic and lymphangiogenic processes within engineered tumor microenvironments.
• Assessing drug efficacy and mechanisms of action within these controlled systems.

Main Results:

• Tumor-on-a-chip technology provides high reproducibility and reliability in studying tumor pathophysiology.
• Microfluidic platforms enable precise manipulation for validating drug combinations and assessing treatment factors.
• The study discusses drug mechanisms related to tumor growth, angiogenesis, and lymphangiogenesis.

Conclusions:

• Tumor-on-a-chip technology is a powerful tool for understanding tumor dynamics and microenvironments.
• This technology facilitates the prediction of drug effectiveness and the development of personalized cancer therapies.
• Future applications hold significant promise for advancing drug development and cancer treatment strategies.